Johanna Mielke und Novartis Pharma - Info zur Person

(1 - 10 von 10

)

Xing: Dr. Johanna Mielke

Dr. / Data Scientist / Wuppertal / Biostatistik, Methodenentwicklung, SAS, Biometrie, Klinische Studien / , TU Dortmund, Novartis Pharma GmbH

A longitudinal Item Response Theory model to characterize ...PAGE meetings

www.page-meeting.org

von M Vandemeulebroecke — Marc Vandemeulebroecke, Johanna Mielke, Peter Quarg, Tillmann Krahnke, Björn Bornkamp, Andreas Monsch. Novartis Pharma AG; Memory Clinic Basel. von M Vandemeulebroecke — Marc Vandemeulebroecke, Johanna Mielke, Peter Quarg, Tillmann Krahnke, Björn Bornkamp, Andreas Monsch. Novartis Pharma AG; Memory Clinic Basel.

S1 Proof of Proposition 1中央研究院

www3.stat.sinica.edu.tw

Joachim Kunert, Johanna Mielke. Department of Statistics, TU Dortmund, Germany. Novartis Pharma AG, Basel, Switzerland. Supplementary Material. S1 Proof of ... Joachim Kunert, Johanna Mielke. Department of Statistics, TU Dortmund, Germany. Novartis Pharma AG, Basel, Switzerland. Supplementary Material. S1 Proof of ...

Welcome to the Population Approach Group in Europe

www.page-meeting.org

D-08 Marc Vandemeulebroecke A longitudinal Item Response Theory model to characterize cognition over time in elderly subjects. Marc Vandemeulebroecke, Johanna Mielke, Peter Quarg, Tillmann Krahnke, Björn Bornkamp, Andreas Monsch. Novartis Pharma AG; Memory Clinic Basel. Objectives: The goals of this work ...

EFFICIENT DESIGNS FOR THE ESTIMATION OF MIXED ...jstor

www.jstor.org

von J Kunert · · Zitiert von: 2 — Joachim Kunert and Johanna Mielke. University of Dortmund and Novartis Pharma ... Johanna Mielke. Novartis Pharma AGNovartis Campus, CH von J Kunert · · Zitiert von: 2 — Joachim Kunert and Johanna Mielke. University of Dortmund and Novartis Pharma ... Johanna Mielke. Novartis Pharma AGNovartis Campus, CH

Incorporating historical information in biosimilar trials: challenges ...

anstat.uni-bremen.de

WebTalk by Johanna Mielke, Novartis Pharma AG For the approval of biosimilars, it is, in most cases, necessary to conduct large Phase III clinical trials in patients to convince the …

Alle Infos zum Namen "Johanna Mielke"

EFFICIENT DESIGNS FOR THE ESTIMATION OF MIXED ...EBSCO Information Services

search.ebscohost.com

von J Kunert · · Zitiert von: 2 — Joachim Kunert and Johanna Mielke. University of Dortmund and Novartis Pharma AG (Received April 2018; accepted August 2019) ... von J Kunert · · Zitiert von: 2 — Joachim Kunert and Johanna Mielke. University of Dortmund and Novartis Pharma AG (Received April 2018; accepted August 2019) ...

of mixed and self carryover effects中央研究院

www3.stat.sinica.edu.tw

von J Kunert · · Zitiert von: 2 — Joachim Kunert and Johanna Mielke. University of Dortmund and Novartis Pharma AG. Abstract: Biosimilars are copies of biological medicines developed after ... von J Kunert · · Zitiert von: 2 — Joachim Kunert and Johanna Mielke. University of Dortmund and Novartis Pharma AG. Abstract: Biosimilars are copies of biological medicines developed after ...

Clinical trials for authorized biosimilars in the European Unioneuropepmc.org › articles › bin › bcp s001

europepmc.org

Johanna Mielke. 1Statistical Methodology, Novartis Pharma AG, 4056, Basel, Switzerland. Find articles by Johanna Mielke ...

JSM Online Program

ww2.amstat.org

10:35 AM, Clinical Trial Design of Authorized Biosimilars in Europe — Johanna Mielke, Novartis Pharma AG ; Bernd Jilma, Medical University ...

Verwandte Suchanfragen zu Johanna Mielke

Anita Thieler
Franz Koenig
Olaf Mersmann

Byron Jones
Stefanie Plettner
Johanna Onuma Mielke

Sabrina Petrikowski
Gernot Taufmann
Janina Loske

Person "Mielke" (16)
Vorname "Johanna" (22260)
Name "Mielke" (1425)

sortiert nach Relevanz / Datum

Erweiterte Suche

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Johanna Mielke und Novartis Pharma Person-Info